To determine whether continuous treatment with FTS induces drug resistance in human HCT-116 colon cancer cells (expressing endogenous mutant K-Ras), the cells were grown in the presence of increasing FTS concentrations for 6 months, up to a final concentration of 60 μM. Here, KRAS is linked to malignant colon neoplasm.